TrialPloS one2015

Acyclovir Therapy Reduces the CD4+ T Cell Response against the Immunodominant pp65 Protein from Cytomegalovirus in Immune Competent Individuals.

Annette Pachnio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.